Yukio Matsui
Corporate Officer/Principal presso Astellas Pharma US, Inc.
Provenienza dei contatti di primo grado di Yukio Matsui
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yukio Matsui tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | General Counsel | |
Mercer University | College/University | Doctorate Degree | |
John Marshall Law School (Georgia) | College/University | Graduate Degree | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Dalhousie University | College/University | Undergraduate Degree | |
Florida A&M University | College/University | Undergraduate Degree | |
New York University | College/University | Masters Business Admin | |
McMaster University | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Undergraduate Degree | |
University of Iowa | College/University | Undergraduate Degree | |
Trinity College Dublin | College/University | Undergraduate Degree | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Chairman General Counsel Corporate Officer/Principal | |
University of Utrecht | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | President | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Pharmaceuticals: Major | Chief Executive Officer General Counsel General Counsel | |
Astellas Pharma SpA
Astellas Pharma SpA Pharmaceuticals: MajorHealth Technology Astellas Pharma SpA manufactures and sales pharmaceutical products. The company is headquartered in Assago, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Society For Women's Health Research
Society For Women's Health Research Miscellaneous Commercial ServicesCommercial Services Society For Women's Health Research engages in promoting research on biological differences in disease. The company was founded by Florence Haseltine in 1990 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Public Communications Contact | |
Kellogg School of Management | College/University | Masters Business Admin | |
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
C4 THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Public Communications Contact | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
AMRYT PHARMA PLC | Pharmaceuticals: Major | Public Communications Contact | |
Astellas Pharmaceuticals AG | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 30 |
Canada | 3 |
Regno Unito | 3 |
Irlanda | 2 |
Giappone | 2 |
Settori
Health Technology | 22 |
Consumer Services | 12 |
Commercial Services | 5 |
Health Services | 2 |
Posizioni
Corporate Officer/Principal | 30 |
Sales & Marketing | 8 |
Chief Tech/Sci/R&D Officer | 6 |
Undergraduate Degree | 6 |
Director/Board Member | 6 |
Contatti più connessi
- Borsa valori
- Insiders
- Yukio Matsui
- Connessioni Società